2024 Q2 Form 10-Q Financial Statement
#000010198424000068 Filed on May 06, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $90.45M | $91.90M |
YoY Change | -15.77% | -15.2% |
Cost Of Revenue | $64.50M | $65.91M |
YoY Change | -22.08% | -21.24% |
Gross Profit | $25.95M | $25.99M |
YoY Change | 5.42% | 5.24% |
Gross Profit Margin | 28.69% | 28.28% |
Selling, General & Admin | $21.33M | $24.01M |
YoY Change | -15.57% | -10.35% |
% of Gross Profit | 82.19% | 92.39% |
Research & Development | $7.520M | $7.821M |
YoY Change | -11.36% | -6.45% |
% of Gross Profit | 28.98% | 30.09% |
Depreciation & Amortization | $3.300M | $4.668M |
YoY Change | -45.14% | -17.99% |
% of Gross Profit | 12.72% | 17.96% |
Operating Expenses | $28.85M | $31.83M |
YoY Change | -14.52% | -9.42% |
Operating Profit | -$4.453M | -$6.908M |
YoY Change | -51.24% | -88.39% |
Interest Expense | -$843.0K | -$922.0K |
YoY Change | -54.23% | -5.44% |
% of Operating Profit | ||
Other Income/Expense, Net | -$89.00K | -$80.00K |
YoY Change | -306.98% | -62.62% |
Pretax Income | -$5.385M | -$7.910M |
YoY Change | -50.74% | -86.97% |
Income Tax | $2.800M | $700.0K |
% Of Pretax Income | ||
Net Earnings | -$8.193M | -$8.649M |
YoY Change | -21.3% | -85.91% |
Net Earnings / Revenue | -9.06% | -9.41% |
Basic Earnings Per Share | -$0.63 | -$0.67 |
Diluted Earnings Per Share | -$0.63 | -$0.67 |
COMMON SHARES | ||
Basic Shares Outstanding | 12.89M shares | 12.97M shares |
Diluted Shares Outstanding | 12.92M shares | 12.90M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $23.13M | $26.91M |
YoY Change | -58.57% | -52.7% |
Cash & Equivalents | $23.13M | $26.91M |
Short-Term Investments | ||
Other Short-Term Assets | $11.13M | $11.76M |
YoY Change | 94.21% | 71.38% |
Inventory | $87.49M | $83.24M |
Prepaid Expenses | ||
Receivables | $93.11M | $92.63M |
Other Receivables | $5.691M | $6.854M |
Total Short-Term Assets | $226.1M | $230.2M |
YoY Change | -19.45% | -23.86% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $39.26M | $42.14M |
YoY Change | -50.02% | -31.8% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $1.404M | $1.469M |
YoY Change | -80.54% | -25.24% |
Total Long-Term Assets | $87.87M | $92.71M |
YoY Change | -20.99% | -19.1% |
TOTAL ASSETS | ||
Total Short-Term Assets | $226.1M | $230.2M |
Total Long-Term Assets | $87.87M | $92.71M |
Total Assets | $314.0M | $322.9M |
YoY Change | -19.89% | -22.55% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $55.52M | $49.76M |
YoY Change | 16.0% | -1.99% |
Accrued Expenses | $38.98M | $42.14M |
YoY Change | -12.89% | -9.07% |
Deferred Revenue | $4.017M | $3.677M |
YoY Change | 83.26% | 90.03% |
Short-Term Debt | $41.00M | $46.00M |
YoY Change | -45.33% | -45.88% |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $141.0M | $138.7M |
YoY Change | -19.06% | -26.17% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $719.0K | $725.0K |
YoY Change | -95.42% | -6.93% |
Total Long-Term Liabilities | $719.0K | $725.0K |
YoY Change | -95.42% | -6.93% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $141.0M | $138.7M |
Total Long-Term Liabilities | $719.0K | $725.0K |
Total Liabilities | $154.2M | $153.3M |
YoY Change | -19.65% | -25.56% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $215.6M | $223.8M |
YoY Change | -16.73% | -16.9% |
Common Stock | $341.0M | $339.1M |
YoY Change | 2.62% | 2.85% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | $371.8M | $371.2M |
YoY Change | 0.75% | 0.6% |
Treasury Stock Shares | ||
Shareholders Equity | $159.8M | $169.7M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $314.0M | $322.9M |
YoY Change | -19.89% | -22.55% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$8.193M | -$8.649M |
YoY Change | -21.3% | -85.91% |
Depreciation, Depletion And Amortization | $3.300M | $4.668M |
YoY Change | -45.14% | -17.99% |
Cash From Operating Activities | $5.450M | -$2.775M |
YoY Change | -64.33% | 37.04% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $2.638M | $1.347M |
YoY Change | -38.23% | -58.69% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$2.638M | -$2.366M |
YoY Change | -38.23% | -51.02% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -5.611M | -$10.23M |
YoY Change | -44.13% | 168.36% |
NET CHANGE | ||
Cash From Operating Activities | 5.450M | -$2.775M |
Cash From Investing Activities | -2.638M | -$2.366M |
Cash From Financing Activities | -5.611M | -$10.23M |
Net Change In Cash | -2.799M | -$15.84M |
YoY Change | -389.75% | 61.04% |
FREE CASH FLOW | ||
Cash From Operating Activities | $5.450M | -$2.775M |
Capital Expenditures | $2.638M | $1.347M |
Free Cash Flow | $2.812M | -$4.122M |
YoY Change | -74.46% | -22.02% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent | |
CY2023Q4 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
65912000 | usd |
CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
83684000 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
25988000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
24693000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7821000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8360000 | usd |
CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1064000 | usd |
CY2023Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
0 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
24011000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
26782000 | usd |
CY2024Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2023Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
49075000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6908000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-59524000 | usd |
CY2024Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-922000 | usd |
CY2023Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-975000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-80000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-214000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-7910000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-60713000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
739000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
650000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8649000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-61363000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.67 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.81 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.67 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-4.81 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12902000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12749000 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12902000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12749000 | shares |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8649000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-61363000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-1591000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
1916000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-10240000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-59447000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
178920000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-1591000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
301000 | usd |
CY2024Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
1230000 | usd |
CY2024Q1 | ueic |
Shares Issued To Directors Value
SharesIssuedToDirectorsValue
|
0 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1904000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
169655000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
268406000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-61363000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
1916000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
352000 | usd |
CY2023Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
812000 | usd |
CY2023Q1 | ueic |
Shares Issued To Directors Value
SharesIssuedToDirectorsValue
|
0 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2540000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
211039000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8649000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-61363000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4668000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5692000 | usd |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1000 | usd |
CY2024Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-3000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
701000 | usd |
CY2024Q1 | ueic |
Shares Issued For Employee Benefit Plan
SharesIssuedForEmployeeBenefitPlan
|
301000 | usd |
CY2023Q1 | ueic |
Shares Issued For Employee Benefit Plan
SharesIssuedForEmployeeBenefitPlan
|
352000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1904000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2540000 | usd |
CY2024Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2023Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
49075000 | usd |
CY2024Q1 | us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
0 | usd |
CY2023Q1 | us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
49000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-11007000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-7723000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-4132000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-18056000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
3051000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1408000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-12517000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-26051000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-567000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-208000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2775000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2025000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1347000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3261000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1019000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1570000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2366000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4831000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
24000000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
14000000 | usd |
CY2024Q1 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
33000000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
17000000 | usd |
CY2024Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1230000 | usd |
CY2023Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
812000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-10230000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3812000 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-466000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
834000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-15837000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-9834000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
42751000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
66740000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
26914000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
56906000 | usd |
CY2024Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
777000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
2065000 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1368000 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1413000 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, we evaluate our estimates and assumptions, including those related to revenue recognition; allowance for credit losses; inventory valuation; impairment of long-lived assets, intangible assets and goodwill; business combinations; income taxes and related valuation allowances and stock-based compensation expense. Actual results may differ from these assumptions and estimates, and they may be adjusted as more information becomes available. Any adjustment may be material.</span></div> | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
26914000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
42751000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
91900000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
108377000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
91900000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
108377000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
93840000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
106182000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
803000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
815000 | usd |
CY2024Q1 | ueic |
Allowance For Sales Returns
AllowanceForSalesReturns
|
410000 | usd |
CY2023Q4 | ueic |
Allowance For Sales Returns
AllowanceForSalesReturns
|
532000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
92627000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
104835000 | usd |
CY2024Q1 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
6854000 | usd |
CY2023Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
7761000 | usd |
CY2024Q1 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
99481000 | usd |
CY2023Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
112596000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
815000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
957000 | usd |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1000 | usd |
CY2024Q1 | ueic |
Allowance For Doubtful Accounts Receivable Write Offs And Effect Of Exchange Rate
AllowanceForDoubtfulAccountsReceivableWriteOffsAndEffectOfExchangeRate
|
12000 | usd |
CY2023Q1 | ueic |
Allowance For Doubtful Accounts Receivable Write Offs And Effect Of Exchange Rate
AllowanceForDoubtfulAccountsReceivableWriteOffsAndEffectOfExchangeRate
|
178000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
803000 | usd |
CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
780000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
3501000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
1931000 | usd |
CY2024Q1 | ueic |
Contract With Customer Liability Payments Received
ContractWithCustomerLiabilityPaymentsReceived
|
1837000 | usd |
CY2023Q1 | ueic |
Contract With Customer Liability Payments Received
ContractWithCustomerLiabilityPaymentsReceived
|
1687000 | usd |
CY2024Q1 | ueic |
Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
|
938000 | usd |
CY2023Q1 | ueic |
Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
|
916000 | usd |
CY2024Q1 | ueic |
Contract With Customer Liability Foreign Exchange Effects
ContractWithCustomerLiabilityForeignExchangeEffects
|
-16000 | usd |
CY2023Q1 | ueic |
Contract With Customer Liability Foreign Exchange Effects
ContractWithCustomerLiabilityForeignExchangeEffects
|
0 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
4384000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2702000 | usd |
CY2024Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
29476000 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
32794000 | usd |
CY2024Q1 | us-gaap |
Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
|
10979000 | usd |
CY2023Q4 | us-gaap |
Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
|
11061000 | usd |
CY2024Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
3438000 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
3827000 | usd |
CY2024Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
39343000 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
40591000 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
83236000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
88273000 | usd |
CY2024Q1 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
59383000 | usd |
CY2023Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
63312000 | usd |
CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
165000000 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
163300000 | usd |
CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
3400000 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
4600000 | usd |
CY2023Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
49100000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
43693000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
18561000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
25132000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
46366000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
21017000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
25349000 | usd |
CY2024Q1 | ueic |
Finite Lived Intangible Assets Fully Amortized Gross
FiniteLivedIntangibleAssetsFullyAmortizedGross
|
48500000 | usd |
CY2023Q4 | ueic |
Finite Lived Intangible Assets Fully Amortized Gross
FiniteLivedIntangibleAssetsFullyAmortizedGross
|
45000000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1236000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1065000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
3920000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
4677000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
4030000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
3219000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
2591000 | usd |
CY2024Q1 | ueic |
Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
|
6695000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
25132000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
16006000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
17239000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
18693000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4529000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4813000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
11477000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
12560000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
16006000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
17373000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1859000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1868000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1745000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1831000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y10M24D | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y10M24D | |
CY2024Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0506 | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0504 | |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
4007000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
4448000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
3426000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
2681000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1228000 | usd |
CY2024Q1 | ueic |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
2479000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
18269000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
2263000 | usd |
CY2024Q1 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
46000000 | usd |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
55000000 | usd |
CY2024Q1 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
6200000 | usd |
CY2024Q1 | us-gaap |
Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
|
1300000 | usd |
CY2023Q1 | us-gaap |
Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
|
1400000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
700000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
700000 | usd |
CY2024Q1 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
3400000 | usd |
CY2024Q1 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
1417000 | usd |
CY2023Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
2843000 | usd |
CY2024Q1 | ueic |
Accrued Employee Sales Commission Current
AccruedEmployeeSalesCommissionCurrent
|
336000 | usd |
CY2023Q4 | ueic |
Accrued Employee Sales Commission Current
AccruedEmployeeSalesCommissionCurrent
|
602000 | usd |
CY2024Q1 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
4469000 | usd |
CY2023Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
4085000 | usd |
CY2024Q1 | ueic |
Accrued Social Insurance Current
AccruedSocialInsuranceCurrent
|
6825000 | usd |
CY2023Q4 | ueic |
Accrued Social Insurance Current
AccruedSocialInsuranceCurrent
|
7082000 | usd |
CY2024Q1 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
3320000 | usd |
CY2023Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
3252000 | usd |
CY2024Q1 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
2022000 | usd |
CY2023Q4 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
2441000 | usd |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
18389000 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
20305000 | usd |
CY2024Q1 | ueic |
Accrued Severance Current
AccruedSeveranceCurrent
|
32000 | usd |
CY2023Q4 | ueic |
Accrued Severance Current
AccruedSeveranceCurrent
|
100000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
3677000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2697000 | usd |
CY2024Q1 | ueic |
Accrued Duties Current
AccruedDutiesCurrent
|
542000 | usd |
CY2023Q4 | ueic |
Accrued Duties Current
AccruedDutiesCurrent
|
481000 | usd |
CY2024Q1 | ueic |
Accrued Expense Associated With Fulfilled Performance Obligations
AccruedExpenseAssociatedWithFulfilledPerformanceObligations
|
941000 | usd |
CY2023Q4 | ueic |
Accrued Expense Associated With Fulfilled Performance Obligations
AccruedExpenseAssociatedWithFulfilledPerformanceObligations
|
1092000 | usd |
CY2024Q1 | ueic |
Accrued Freight And Handling Fees Current
AccruedFreightAndHandlingFeesCurrent
|
1630000 | usd |
CY2023Q4 | ueic |
Accrued Freight And Handling Fees Current
AccruedFreightAndHandlingFeesCurrent
|
1998000 | usd |
CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
374000 | usd |
CY2023Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
438000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4529000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4813000 | usd |
CY2024Q1 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
522000 | usd |
CY2023Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
522000 | usd |
CY2024Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1539000 | usd |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1558000 | usd |
CY2024Q1 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
2192000 | usd |
CY2023Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
4194000 | usd |
CY2024Q1 | ueic |
Other Accrued Expenses Current
OtherAccruedExpensesCurrent
|
3783000 | usd |
CY2023Q4 | ueic |
Other Accrued Expenses Current
OtherAccruedExpensesCurrent
|
3388000 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
19729000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
21181000 | usd |
CY2024Q1 | ueic |
Accrued Property Plant And Equipment Purchases
AccruedPropertyPlantAndEquipmentPurchases
|
400000 | usd |
CY2023Q4 | ueic |
Accrued Property Plant And Equipment Purchases
AccruedPropertyPlantAndEquipmentPurchases
|
200000 | usd |
CY2023Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
522000 | usd |
CY2022Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
522000 | usd |
CY2024Q1 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
0 | usd |
CY2023Q1 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
0 | usd |
CY2024Q1 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
0 | usd |
CY2023Q1 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
0 | usd |
CY2024Q1 | us-gaap |
Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
|
0 | usd |
CY2023Q1 | us-gaap |
Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
|
0 | usd |
CY2024Q1 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
522000 | usd |
CY2023Q1 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
522000 | usd |
CY2023Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
462000 | usd |
CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1064000 | usd |
CY2024Q1 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
1330000 | usd |
CY2024Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
196000 | usd |
CY2024Q1 | us-gaap |
Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
|
5079000 | usd |
CY2024Q1 | us-gaap |
Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
|
934000 | usd |
CY2024Q1 | ueic |
Number Of Inter Partes Review Ipr Requests Denied
NumberOfInterPartesReviewIPRRequestsDenied
|
14 | inter_partes_review |
CY2024Q1 | ueic |
Number Of Inter Partes Review Ipr Requests Granted
NumberOfInterPartesReviewIPRRequestsGranted
|
12 | inter_partes_review |
CY2024Q1 | ueic |
Number Of Patents Subject To Inter Partes Review Ipr
NumberOfPatentsSubjectToInterPartesReviewIPR
|
2 | patent |
CY2024Q1 | ueic |
Number Of Inter Partes Review Ipr Requests Granted
NumberOfInterPartesReviewIPRRequestsGranted
|
12 | inter_partes_review |
CY2021Q2 | ueic |
Number Of Customers With A Filed Complaint
NumberOfCustomersWithAFiledComplaint
|
2 | customer |
CY2021Q2 | ueic |
Number Of Customers With A Filed Complaint
NumberOfCustomersWithAFiledComplaint
|
2 | customer |
CY2024Q1 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
35000000 | cny |
CY2024Q1 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
35000000 | cny |
CY2024Q1 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
4900000 | usd |
CY2024Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
140000 | shares |
CY2023Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
53000 | shares |
CY2024Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
1230000 | usd |
CY2023Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
812000 | usd |
CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1904000 | usd |
CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2540000 | usd |
CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
287000 | usd |
CY2023Q1 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
410000 | usd |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-4.81 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
901000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
38.78 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
122000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
58.52 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
779000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
35.67 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y10M13D | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
779000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
35.67 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P3Y10M13D | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
585000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
38.65 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y2M15D | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-20000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-194000 | usd |
CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-84000 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-238000 | usd |
CY2024Q1 | ueic |
Other Income Expense
OtherIncomeExpense
|
24000 | usd |
CY2023Q1 | ueic |
Other Income Expense
OtherIncomeExpense
|
218000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-80000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-214000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8649000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-61363000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12902000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12749000 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.67 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.81 | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8649000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-61363000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12902000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12749000 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12902000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12749000 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.67 | |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |